About Surfix
Surfix is a company based in Wageningen (Netherlands) founded in 2021. Surfix has raised $19.51 million across 3 funding rounds from investors including LioniX International, European Union and PhotonDelta. Surfix offers products and services including Photonic Diagnostics Platform, Photonic Biosensor, and Dedicated Desktop Reader. Surfix operates in a competitive market with competitors including NuvoAir, MedTel Healthcare, Neurosynaptic, WuXi Diagnostics and Coagulo, among others.
- Headquarter Wageningen, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.51 M (USD)
in 3 rounds
-
Latest Funding Round
$294.98 K (USD), Grant
Jan 01, 2023
-
Investors
LioniX International
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Surfix
Surfix offers a comprehensive portfolio of products and services, including Photonic Diagnostics Platform, Photonic Biosensor, and Dedicated Desktop Reader.
Platform for precise disease detection and management at point-of-care.
Component for sensitive biomarker detection in healthcare applications.
Compact device for reading biosensor data in point-of-care settings.
People of Surfix
Unlock access to complete
Funding Insights of Surfix
Surfix has successfully raised a total of $19.51M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $294.98 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Surfix
Surfix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include LioniX International, European Union and PhotonDelta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Develops non-invasive diagnostics for early cancer detection and biomarker analysis.
|
Locked | Locked | Locked |
Investor details for Surfix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Surfix
Investment portfolio details for Surfix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Surfix
Detailed financials for Surfix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surfix Comparisons
Peer comparison for Surfix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Surfix
Surfix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, MedTel Healthcare, Neurosynaptic, WuXi Diagnostics and Coagulo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical decision support tools for respiratory diseases are provided.
|
|
| Locked | Locked | Locked |
Remote patient monitoring software is developed for healthcare providers.
|
|
| Locked | Locked | Locked |
ICT-based products and solutions are developed for healthcare.
|
|
| Locked | Locked | Locked |
Diagnostic solutions for disease identification are offered to healthcare providers.
|
|
| Locked | Locked | Locked |
Precision-medicine platform for blood coagulation disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Molecular-level home analysis and monitoring for personalized healthcare is offered.
|
Detailed competitors of Surfix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surfix
Complete news archive for Surfix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surfix
Surfix was founded in 2021.
Surfix is headquartered in Wageningen, Netherlands. It is registered at Wageningen, Gelderland, Netherlands.
Surfix is a funded company, having raised a total of $19.51M across 3 funding rounds to date.
Surfix was founded in 2021 in Wageningen, Netherlands, as a provider in the healthcare diagnostics sector. A photonics-based platform is offered by the company to support laboratory testing of samples. Diagnostic solutions are enabled through this technology for medical applications. Operations focus on developing and deploying the platform across healthcare environments in Europe.
Surfix's top competitors include MedTel Healthcare, Neurosynaptic and WuXi Diagnostics.
Surfix offers Photonic Diagnostics Platform, Photonic Biosensor, and Dedicated Desktop Reader.
Surfix has 5 investors. Key investors include LioniX International, European Union, PhotonDelta, Oost NL, and Qurin Diagnostics.